Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: An open prospective comparative study

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 10, 2007, Pages 1381-1385

  Bhatnagar, A ^a   Kanwar, A J ^a   Parsad, D ^a   De, D ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

NBUVB; PUVA; Repigmentation; Stability; VIDA score

Indexed keywords

TRIMETHYLPSORALEN;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MALE; NARROW BAND ULTRAVIOLET B RADIATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUVA; RANDOMIZED CONTROLLED TRIAL; SKIN PIGMENTATION; TREATMENT DURATION; ULTRAVIOLET B RADIATION; VITILIGO;

ADULT; CHI-SQUARE DISTRIBUTION; FEMALE; FICUSIN; HUMANS; MALE; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; PUVA THERAPY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITILIGO;

EID: 35649027933     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02283.x     Document Type: Article

References (13)

1. Njoo MD, Das PK, Bos JD, Westerhof W. Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol 1999; 135: 407-413.
2. El Mofty AM. A preliminary clinical report on the treatment of leucoderma with Ammi majjus Linn. J Egypt Med Assoc, 1948; 31: 651-665.
3. Pathak MA, Fitzpatrick TB. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD. J Photochem Photobiol B 1992; 14: 3-22.
4. Fitzpatrick TB, Pathak MA. Research and development of oral psoralen and longwave radiation photochemotherapy: 2000 B.C.-1982 A.D. Natl Cancer Inst Monogr 1984; 66: 3-11.
5. Westerhof W, Nieuweboer-Krobotova LN. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997; 133: 1525-1528.
6. Njoo MD, Spuls PI, Bos JD, Westerhof W, Bossuyt PM. Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of literature. Arch Dermatol 1998; 134: 1532-1540.
7. Njoo MD, Bos JD, Westerhof W. Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol 2000; 42: 245-253.
8. Kanwar AJ, Dogra S, Parsad D, Kumar B. Narrow-band UVB for treatment of vitiligo: An emerging effective and well tolerated therapy. Int J Dermatol 2005; 44: 57-60.
9. Kanwar AJ, Dogra S. Narrow-band UVB for the treatment of generalized vitiligo in children. Clin Exp Dermatol 2005; 30: 332-336.
10. Parsad D, Kanwar AJ, Kumar B. Psoralen-ultraviolet A vs narrow-band ultraviolet B phototherapy for the treatment of vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 175-177.
11. Cui J, Arita Y, Bystryn JC. Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol 1993; 100: 812-815.
12. Lerner AB. Vitiligo. J Invest Dermatol 1959; 32: 285-310.
13. Hann SK, Chun WK, Park YK. Clinical characteristic of progressive vitiligo. Int J Dermatol 1997; 36: 353-355.